Hence, in this study, using a chronic intraperitoneal rotenone treatment as an in vivo PD model, we examined the neuroprotective efficacy of Val against rotenone induced oxidative stress, neuroinflammation, α-synuclein expression and dopaminergic neuronal loss. The gene discussed is SNCA; the disease is Parkinson disease.